Join the Lymphoma Research Foundation as we celebrate 10 years of riding toward a future without lymphoma! More >

This memorable event brings together important leaders from the lymphoma community, including members of our SAB and Board of Directors, our pharmaceutical industry partners, health care providers, patients, advocates, and volunteers. More >

The U.S. Food and Drug Administration (FDA) announced it has approved the use of ofatumumab (Arzerra) to treat patients with relapsed chronic lymphocytic leukemia (CLL). More >

1
2
3

Learn From Experts

The FocusOnCLL.org website is designed to provide helpful information and resources to patients, caregivers, physicians, and others affected by chronic lymphocytic leukemia (CLL).

Learn about CLL, treatment options, research and more from exclusive interviews with some of the world's leading lymphoma experts.

Learn more

Getting the Facts

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are B-cell malignancies. CLL and SLL are essentially the same disease, with slightly different manifestations. CLL tends to be an indolent (slow-growing) cancer. However, over time, it can progress to a more aggressive type of lymphoma. Approximately 15,000 new cases of CLL are diagnosed annually.

Hear From the Community

Everyone's lymphoma story is unique and special.  

Read about CLL patients, survivors and caregivers' journey with the disease, lessons learned and words of advice.

Ask the Doctor

The Lymphoma Research Foundation’s Ask the Doctor About Lymphoma program is a national series of community based-programs, providing patient with updates on the disease and new treatment options.

Youtube

Subscribe to LRF's YouTube Channel for videos on lymphoma, treatment options, and clinical trials. Gain access to in-depth videos with leading lymphoma experts.